Literature DB >> 6317774

Use of cloned probes to detect Epstein-Barr viral DNA in tissues of patients with neoplastic and lymphoproliferative diseases.

W Andiman, L Gradoville, L Heston, R Neydorff, M E Savage, G Kitchingman, D Shedd, G Miller.   

Abstract

Cloned fragments of the Epstein-Barr virus (EBV) genome were used to examine tissues from 145 patients for the presence of EBV DNA by two techniques: (1) nucleic acid hybridization of cell spots from which the DNA had been extracted in situ and (2) hybridization of DNA that had been transferred to nitrocellulose by Southern blotting. EBV DNA was found in tissues from four adults and five children with American Burkitt's lymphoma, infectious mononucleosis, lymphoma following bone marrow transplant, central nervous system lymphoma, nasopharyngeal carcinoma, and fatal polyclonal B-cell lymphoma following mononucleosis; two patients also had chronic pneumonitis, failure to thrive, and abnormal immune function. Six of the nine patients whose tissues contained EBV DNA had a demonstrable or presumed associated immunologic disorder. EBV DNA was not found in normal tissues or in a variety of hematologic neoplasms and other disorders. Nucleic acid hybridization methods can be used for the routine examination of the association of EBV with lymphomas and other lymphoproliferative syndromes occurring in immunodeficient individuals.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6317774     DOI: 10.1093/infdis/148.6.967

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  24 in total

1.  Detection of Epstein-Barr virus by in situ hybridization. Progress toward development of a nonisotopic diagnostic test.

Authors:  R Bashir; F Hochberg; R H Singer
Journal:  Am J Pathol       Date:  1989-12       Impact factor: 4.307

2.  B-cell lymphoproliferation and lymphomagenesis are associated with clonotypic intracellular terminal regions of the Epstein-Barr virus.

Authors:  N A Brown; C R Liu; Y F Wang; C R Garcia
Journal:  J Virol       Date:  1988-03       Impact factor: 5.103

3.  Construction of a gentamicin resistance gene probe for epidemiological studies.

Authors:  D J Groot Obbink; L J Ritchie; F H Cameron; J S Mattick; V P Ackerman
Journal:  Antimicrob Agents Chemother       Date:  1985-07       Impact factor: 5.191

Review 4.  Diagnostic deoxyribonucleic acid probes for infectious diseases.

Authors:  F C Tenover
Journal:  Clin Microbiol Rev       Date:  1988-01       Impact factor: 26.132

5.  Detection of Epstein-Barr virus genomes in Hodgkin's disease: relation to age.

Authors:  R F Jarrett; A Gallagher; D B Jones; F E Alexander; A S Krajewski; A Kelsey; J Adams; B Angus; S Gledhill; D H Wright
Journal:  J Clin Pathol       Date:  1991-10       Impact factor: 3.411

6.  Detection of Epstein-Barr virus DNA in mouthwashes by hybridization.

Authors:  R F Ambinder; J R Wingard; W H Burns; S D Hayward; R Saral; H R Perry; G W Santos; G S Hayward
Journal:  J Clin Microbiol       Date:  1985-03       Impact factor: 5.948

7.  The vector homology problem in diagnostic nucleic acid hybridization of clinical specimens.

Authors:  R F Ambinder; P Charache; S Staal; P Wright; M Forman; S D Hayward; G S Hayward
Journal:  J Clin Microbiol       Date:  1986-07       Impact factor: 5.948

8.  In situ demonstration of Epstein-Barr viral genomes in viral-associated B cell lymphoproliferations.

Authors:  L M Weiss; L A Movahed
Journal:  Am J Pathol       Date:  1989-03       Impact factor: 4.307

9.  Sinonasal and laryngeal carcinoma in children: correlation of imaging characteristics with clinicopathologic and cytogenetic features.

Authors:  C D Robson; R Rahbar; S O Vargas; K J Marcus; J W Mack; G R Licameli; H E Grier
Journal:  AJNR Am J Neuroradiol       Date:  2009-09-24       Impact factor: 3.825

10.  The frequency of Epstein-Barr virus infection and associated lymphoproliferative syndrome after transplantation and its manifestations in children.

Authors:  M Ho; R Jaffe; G Miller; M K Breinig; J S Dummer; L Makowka; R W Atchison; F Karrer; M A Nalesnik; T E Starzl
Journal:  Transplantation       Date:  1988-04       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.